Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Infect Control ; 47(3): 337-339, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30442444

RESUMO

According to the US Advisory Committee on Immunization Practices recommendations, only health care personnel (HCP) with adequate evidence of immunity should be exposed to patients with a suspected diagnosis of mumps. Here we report a hospital-outbreak scenario among medical residents with no previous vaccination record against mumps who had a high rate of complications. We also describe the importance and impact of full and proper vaccination, as well as isolation, of HCP in stopping the outbreak and, finally, review opportunities for improving the safety of HCP.


Assuntos
Infecção Hospitalar/epidemiologia , Surtos de Doenças , Pessoal de Saúde , Caxumba/epidemiologia , Adulto , Infecção Hospitalar/complicações , Feminino , Hospitais de Ensino , Humanos , Controle de Infecções/métodos , Masculino , Caxumba/complicações , Universidades
2.
Rev Med Inst Mex Seguro Soc ; 57(1): 30-35, 2019 Apr 01.
Artigo em Espanhol | MEDLINE | ID: mdl-31071252

RESUMO

The residual risk of transfusion-related infections has decreased dramatically in countries that have routinely implemented serological screening. Most of the donation in Mexico is from replacement practice, a risk factor for positive serology. In Mexico, the altruistic donation is only 2.7%. The heterogeneity of technical factors, regional factors and internal policies of each center influences the variability of data on the prevalence of positive screening, as well as the prevalence of confirmed cases. The main advantage of nucleic acid technology is the detection of donors in the period of serological window or occult infections, being occult hepatitis reports in Mexican donors from 1 to 3.4%. The limitation of available technology, the scope of the clinic and perspectives, invites us to improve technology and health policies in the interest of transfusion safety.


El riesgo residual de las infecciones relacionadas a la transfusión ha disminuido drásticamente en los países que han implementado rutinariamente el tamizaje serológico. La mayor parte de la donación en México es de reposición, factor de riesgo para serología positiva, y en donde la donación altruista es de apenas 2.7%. La heterogeneidad de factores técnicos, regionales y políticas internas de cada centro influyen en la variabilidad de datos en prevalencia del tamizaje positivo, así como en la prevalencia de casos confirmados. La principal ventaja de la tecnología de ácidos nucleicos es la detección de donadores en periodo de ventana serológico o de infecciones ocultas, con reportes de hepatitis ocultas en donadores de 1-3.4% en México. Las limitantes de la tecnología disponible, el alcance de la clínica y de las perspectivas, nos invita a la mejora tecnológica y de las políticas sanitarias en aras de la seguridad transfusional.


Assuntos
Segurança do Sangue/métodos , Transfusão de Sangue/normas , Reação Transfusional/prevenção & controle , Segurança do Sangue/tendências , Transfusão de Sangue/tendências , Humanos , México/epidemiologia , Melhoria de Qualidade/tendências , Reação Transfusional/epidemiologia
3.
Am J Infect Control ; 44(2): 250-2, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26585250

RESUMO

A comparison of 2 different influenza seasons (2013-2014 and 2014-2015) where early vaccination among health care providers (HCPs) in the latter was the difference. Differences in leave of absence because of influenza-like illness (ILI) (52 vs 15 [total number of leave of absence issued], P < .001) and total days of lost work (218 vs 68, P < .001) were found for the 2013-2014 and 2014-2015 seasons, respectively. An association between earlier influenza vaccination among HCPs and a reduction in ILI, leave of absence, and days of lost work was found.


Assuntos
Pessoal de Saúde/estatística & dados numéricos , Vacinas contra Influenza/administração & dosagem , Influenza Humana/prevenção & controle , Vacinação , Hospitais de Ensino , Humanos , Influenza Humana/epidemiologia , México/epidemiologia , Estudos Retrospectivos , Síndrome , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA